Last reviewed · How we verify
NCT05079763
Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation Dermatitis
NA trial testing Bacterial cellulose-monolaurin hydrogel in Acute Radiation Dermatitis in 54 participants. Currently enrolling.
31 December 2028
Quick facts
| Lead sponsor | University of the Philippines |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 54 |
| Start date | 1 September 2021 |
| Primary completion | 31 December 2028 |
| Estimated completion | 31 December 2028 |
| Sites | 1 location across Philippines |
Drugs / interventions tested
- Bacterial cellulose-monolaurin hydrogel
- Placebo cream
Conditions studied
- Acute Radiation Dermatitis — all drugs for Acute Radiation Dermatitis →
Sponsor
University of the Philippines
Who can join
Adults 18 to 80, female only, with Acute Radiation Dermatitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Acute radiation dermatitis (ARD) is almost universally experienced by patients with cancer during or after radiation therapy. This condition potentially leads to detrimental clinical outcomes as it adversely affects adherence to prescribed subsequent management and further worsens quality of life. Nevertheless, there remains no consensus on the appropriate intervention for ARD. This pilot two parallel-group randomized trial aims to clinically assess the potential of bacterial cellulose-monolaurin hydrogel, compared to placebo cream, to prevent high-grade ARD among Filipinos with breast cancer up to four weeks after last radiotherapy session.
Publications & conference data
6 peer-reviewed publications reference this trial (live from Europe PMC):
-
Bacterial immunotherapy: is it a weapon in our arsenal in the fight against cancer?
Sharma S, Sharma H, Gogoi H. · · 2023 · cited 8× · PMID 38090593 · DOI 10.3389/fimmu.2023.1277677 -
A Comprehensive Review of Clinical Studies on Bacterial Cellulose: From the Earliest Uses to Contemporary Innovations.
Meslier T, D'Antin JC, Julio G, Roig A. · · 2025 · cited 3× · PMID 40685851 · DOI 10.1002/adhm.202502189 -
Microorganisms and Breast Cancer: An In-Depth Analysis of Clinical Studies.
Naderi N, Mosahebi A, Williams NR. · · 2023 · cited 2× · PMID 38276152 · DOI 10.3390/pathogens13010006 -
Mechanism-Inspired Biomaterials and Regenerative Therapies for Radiation-Induced Skin Injury.
Zhou Y, Zhang X, Shen X, Xing S, et al · · 2026 · PMID 41858581 · DOI 10.2147/ijn.s568923 -
Recent advances in application of hydrogel-based nanomaterials in breast cancer: from drug delivery, immunotherapy mechanisms to clinical applications.
Xu Y, Pan D, Yang Q, Huang C, et al · · 2026 · PMID 41857574 · DOI 10.1186/s12951-026-04238-z -
Ionizing radiation: molecular mechanisms, biological effects, and therapeutic targets.
Wei W, Ren Y, Lan J, Yi J, et al · · 2026 · PMID 41507636 · DOI 10.1186/s43556-025-00358-4
Verify or expand the search:
- PubMed search for NCT05079763
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Radiation Dermatitis
Currently open trials in the same condition.
- NCT06837831 — Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin · NA · recruiting
Other University of the Philippines trials
Trials by the same sponsor.
- NCT06378489 — The Use of Etonogestrel Contraceptive Implant as Treatment for Endometrial Hyperplasia Without Atypia: A Cohort Study · not yet recruiting
- NCT05518760 — COVID-19 Effectiveness Study in the Philippines · unknown
- NCT05801380 — Monitoring Drug Efficacy in Patients with Alzheimer's Disease · recruiting
- NCT04766281 — MLC901 in Moderate Traumatic Brain Injury · Phase 4 · unknown
- NCT04849637 — Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients · Phase 2 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05079763 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 26 May 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of the Philippines
- Last refreshed: 12 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05079763.